Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus
- PMID: 14980809
- DOI: 10.1016/S0014-4886(03)00312-1
Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus
Abstract
Four groups of rats, sustaining a striatal quinolinic acid (QA) lesion, a pallidal QA lesion, a combined striatal + pallidal lesion, or sham operation, were tested in spontaneous and amphetamine-induced activity, spatial navigation in a water maze, position discrimination and reversal in a wet T maze, and food manipulation. The striatal lesion markedly impaired rats' performance on the motor and cognitive tasks. In contrast, rats sustaining a bilateral lesion to the GP in addition to the striatal lesion performed similarly to sham-operated rats on the motor and cognitive tasks, although they showed a transient decrease in activity levels. Given that a similar dysfunction of basal ganglia circuitry is thought to subserve the behavioral alterations seen in QA-lesioned rats and Huntington's disease (HD) patients, the present results raise the possibility that manipulations of the external segment of the globus pallidus (the primate analogue of the rat GP) could ameliorate some of HD symptoms.
Similar articles
-
Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.Mov Disord. 2003 Dec;18(12):1499-507. doi: 10.1002/mds.10622. Mov Disord. 2003. PMID: 14673887
-
Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.Behav Brain Res. 2007 Jan 25;176(2):216-21. doi: 10.1016/j.bbr.2006.10.004. Epub 2006 Nov 22. Behav Brain Res. 2007. PMID: 17123640
-
Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease.Behav Brain Res. 2004 Jul 9;152(2):375-83. doi: 10.1016/j.bbr.2003.10.021. Behav Brain Res. 2004. PMID: 15196806
-
The role of the human globus pallidus in Huntington's disease.Brain Pathol. 2016 Nov;26(6):741-751. doi: 10.1111/bpa.12429. Brain Pathol. 2016. PMID: 27529459 Free PMC article. Review.
-
Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits.Prog Neurobiol. 2000 Jun;61(3):313-38. doi: 10.1016/s0301-0082(99)00058-1. Prog Neurobiol. 2000. PMID: 10727778 Review.
Cited by
-
Motor sequences and the basal ganglia: kinematics, not habits.J Neurosci. 2010 Jun 2;30(22):7685-90. doi: 10.1523/JNEUROSCI.0163-10.2010. J Neurosci. 2010. PMID: 20519543 Free PMC article.
-
Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.PLoS One. 2013 Sep 11;8(9):e75099. doi: 10.1371/journal.pone.0075099. eCollection 2013. PLoS One. 2013. PMID: 24040390 Free PMC article.
-
Developing stem cell therapies for juvenile and adult-onset Huntington's disease.Regen Med. 2015;10(5):623-46. doi: 10.2217/rme.15.25. Regen Med. 2015. PMID: 26237705 Free PMC article. Review.
-
Deep Brain Stimulation in Huntington's Disease-Preliminary Evidence on Pathophysiology, Efficacy and Safety.Brain Sci. 2016 Aug 30;6(3):38. doi: 10.3390/brainsci6030038. Brain Sci. 2016. PMID: 27589813 Free PMC article. Review.
-
Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.Neuropsychopharmacology. 2012 Aug;37(9):2076-87. doi: 10.1038/npp.2012.56. Epub 2012 Apr 25. Neuropsychopharmacology. 2012. PMID: 22534626 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical